These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 8806979)

  • 41. Olmesartan medoxomil, an angiotensin II receptor blocker ameliorates insulin resistance and decreases triglyceride production in fructose-fed rats.
    Okada K; Hirano T; Ran J; Adachi M
    Hypertens Res; 2004 Apr; 27(4):293-9. PubMed ID: 15127887
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Angiotensin-converting enzyme inhibition attenuates arterial constrictor responses in experimental hypertension.
    Kähönen M; Mäkynen H; Wu X; Arvola P; Pekki A; Pörsti I
    J Pharmacol Exp Ther; 1996 Jun; 277(3):1701-9. PubMed ID: 8667241
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Quinapril reduces arterial blood pressure and improves metabolic control in elderly hypertensive diabetic patients.
    Paolisso G; Gambardella A; Verza M; Varricchio M
    Diabete Metab; 1990; 16(3):264-5. PubMed ID: 2210025
    [No Abstract]   [Full Text] [Related]  

  • 44. Effects of the Chinese medicine, TSJN on insulin resistance and hypertension in fructose-fed rats.
    Li Y; Higashiura K; Ura N; Torii T; Agata J; Wang L; Togashi N; Shimamoto K
    Hypertens Res; 2000 Mar; 23(2):101-7. PubMed ID: 10770256
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Rilmenidine normalizes fructose-induced insulin resistance and hypertension in rats.
    Pénicaud L; Berthault MF; Morin J; Dubar M; Ktorza A; Ferre P
    J Hypertens Suppl; 1998 Aug; 16(3):S45-9. PubMed ID: 9747910
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Insulin receptors and renal sodium handling in hypertensive fructose-fed rats.
    Catena C; Cavarape A; Novello M; Giacchetti G; Sechi LA
    Kidney Int; 2003 Dec; 64(6):2163-71. PubMed ID: 14633139
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Overexpression of vascular endothelin-1 and endothelin-A receptors in a fructose-induced hypertensive rat model.
    Juan CC; Fang VS; Hsu YP; Huang YJ; Hsia DB; Yu PC; Kwok CF; Ho LT
    J Hypertens; 1998 Dec; 16(12 Pt 1):1775-82. PubMed ID: 9869011
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Endothelial function in spontaneously hypertensive rats: influence of quinapril treatment.
    Kähönen M; Mäkynen H; Wu X; Arvola P; Pörsti I
    Br J Pharmacol; 1995 Jul; 115(5):859-67. PubMed ID: 8548188
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inhibition of arterial thrombogenesis by quinapril but not losartan.
    Bavry AA; Li D; Zander DS; Phillips MI; Mehta JL
    J Cardiovasc Pharmacol Ther; 2000 Apr; 5(2):121-7. PubMed ID: 11150391
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Platelet function during antihypertensive treatment with quinapril, a novel angiotensin converting enzyme inhibitor.
    Gupta RK; Kjeldsen SE; Motley E; Weder AB; Zweifler AJ; Julius S
    J Cardiovasc Pharmacol; 1991 Jan; 17(1):13-9. PubMed ID: 1708046
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparative effects of quinapril, atenolol, and verapamil on blood pressure and forearm hemodynamics during handgrip exercise.
    Cléroux J; Beaulieu M; Kouamé N; Lacourcière Y
    Am J Hypertens; 1994 Jun; 7(6):566-70. PubMed ID: 7917158
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Trandolapril and endothelin antagonist LU-135252 in the treatment of the fructose-induced hypertensive, hyperinsulinemic, hypertriglyceridemic rat.
    Ezra-Nimni O; Ezra D; Peleg E; Munter K; Rosenthal T
    Am J Hypertens; 2003 Apr; 16(4):324-8. PubMed ID: 12670751
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Amelioration of insulin resistance and hypertension in a fructose-fed rat model with fish oil supplementation.
    Huang YJ; Fang VS; Juan CC; Chou YC; Kwok CF; Ho LT
    Metabolism; 1997 Nov; 46(11):1252-8. PubMed ID: 9361681
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of quinapril, a new angiotensin-converting enzyme inhibitor, on vasoconstrictor activity in the isolated, perfused mesenteric vasculature of hypertensive rats.
    Major TC; Overhiser RW; Taylor DG; Panek RL
    J Pharmacol Exp Ther; 1993 Apr; 265(1):187-93. PubMed ID: 8474005
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antihypertensive effects of metformin in fructose-fed hyperinsulinemic, hypertensive rats.
    Verma S; Bhanot S; McNeill JH
    J Pharmacol Exp Ther; 1994 Dec; 271(3):1334-7. PubMed ID: 7996443
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of myricetin on blood pressure and metabolic alterations in fructose hypertensive rats.
    Godse S; Mohan M; Kasture V; Kasture S
    Pharm Biol; 2010 May; 48(5):494-8. PubMed ID: 20645789
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hemodynamic and morphological effects of quinapril during genetic hypertension development.
    Richer C; Mulder P; Fornes P; Richard V; Camilleri JP; Giudicelli JF
    J Cardiovasc Pharmacol; 1991 Oct; 18(4):631-42. PubMed ID: 1724542
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Aqueous extract of Monascus purpureus M9011 prevents and reverses fructose-induced hypertension in rats.
    Hsieh PS; Tai YH
    J Agric Food Chem; 2003 Jul; 51(14):3945-50. PubMed ID: 12822928
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Quinapril prevents stroke both during and after the treatment period in stroke-prone spontaneously hypertensive rats.
    Vacher E; Fornes P; Domergue V; Richer C; Bruneval P; Giudicelli JF
    Am J Hypertens; 1993 Nov; 6(11 Pt 1):951-9. PubMed ID: 8305170
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Modification of cardiovascular risk factors during antihypertensive treatment: a multicentre trial with quinapril.
    Manzato E; Capurso A; Crepaldi G
    J Int Med Res; 1993; 21(1):15-25. PubMed ID: 8319817
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.